In Wednesday’s Wall Street session, Planet Labs PBC (NYSE:PL) shares traded at $5.42, down -2.69% from the previous session.
PL stock price is now 32.20% away from the 50-day moving average and 44.57% away from the 200-day moving average. The market capitalization of the company currently stands at $1.64B.
With the price target maintained at $3.50, Goldman recently Downgraded its rating from Buy to Neutral for Planet Labs PBC (NYSE: PL). On January 30, 2025, Craig Hallum Upgraded its previous ‘Hold’ rating to ‘Buy’ on the stock keeping its target price maintained at $7, while ‘Cantor Fitzgerald’ rates the stock as ‘Overweight’
In other news, ISALEA INVESTMENTS LP, Director bought 3,800 shares of the company’s stock on Jun 13 ’25. The stock was bought for $2,443 at an average price of $0.64. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 12 ’25, Director ISALEA INVESTMENTS LP bought 8,600 shares of the business’s stock. A total of $5,850 was incurred on buying the stock at an average price of $0.68. A total of 30.94% of the company’s stock is owned by insiders.
During the past 12 months, Planet Labs PBC has had a low of $1.73 and a high of $6.71. As of last week, the company has a debt-to-equity ratio of 0.04, a current ratio of 2.09, and a quick ratio of 2.09. The fifty day moving average price for PL is $4.0998 and a two-hundred day moving average price translates $3.7491 for the stock.
The latest earnings results from Planet Labs PBC (NYSE: PL) was released for 2025-04-30. The net profit margin was -42.58% and return on equity was -22.54% for PL. The company reported revenue of $66.27 million for the quarter, compared to $60.44 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 9.64 percent.
